Evidence map›Paper›PMID 36507261›Full record

ReviewFrontiers in bioengineering and biotechnology2022

Bioprinting for bone tissue engineering.

Xin Kang, Xiao-Bo Zhang, Xi-Dan Gao, Ding-Jun Hao, Tao Li, Zheng-Wei Xu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xin KangDepartment of Spine Surgery, Honghui Hospital, Xi'an Jiao Tong University, Xian, Shaanxi, China.
Xiao-Bo ZhangDepartment of Spine Surgery, Honghui Hospital, Xi'an Jiao Tong University, Xian, Shaanxi, China.
Xi-Dan GaoDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Ding-Jun HaoDepartment of Spine Surgery, Honghui Hospital, Xi'an Jiao Tong University, Xian, Shaanxi, China.
Tao LiDepartment of Spine Surgery, Honghui Hospital, Xi'an Jiao Tong University, Xian, Shaanxi, China.
Zheng-Wei XuDepartment of Spine Surgery, Honghui Hospital, Xi'an Jiao Tong University, Xian, Shaanxi, China.
Xi'an Honghui Hospital · CNLanzhou University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The shape transformation characteristics of four-dimensional (4D)-printed bone structures can meet the individual bone regeneration needs, while their structure can be programmed to cross-link or reassemble by stimulating responsive materials. At the same time, it can be used to design vascularized bone structures that help establish a bionic microenvironment, thus influencing cellular behavior and enhancing stem cell differentiation in the postprinting phase. These developments significantly improve conventional three-dimensional (3D)-printed bone structures with enhanced functional adaptability, providing theoretical support to fabricate bone structures to adapt to defective areas dynamically. The printing inks used are stimulus-responsive materials that enable spatiotemporal distribution, maintenance of bioactivity and cellular release for bone, vascular and neural tissue regeneration. This paper discusses the limitations of current bone defect therapies, 4D printing materials used to stimulate bone tissue engineering (e.g., hydrogels), the printing process, the printing classification and their value for clinical applications. We focus on summarizing the technical challenges faced to provide novel therapeutic implications for bone defect repair.

Indexed as

bone tissue engineeringchallengesfour-dimensional bioprintingreviewstimulus-responsive

Identifiers

PMID36507261
PMCPMC9732272
OpenAlexW4309933606

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.